IDYA vs INSM Stock Comparison

INSM currently leads IDYA in this stock comparison, with AIQ scores of 57 vs 54. The clearest difference is value, while IDYA has the stronger risk resilience profile.

Market data as of Nov 15, 2026 market close· AIQ score gap 3 points
IDYA
Healthcare
vs
INSM
Healthcare
IDYA
IDEAYA Biosciences, Inc.
Price
$31.83
Day move
+1.08%
AIQ Score
54/100
Best edge
Risk Resilience
Sector
Healthcare
INSM
Insmed Incorporated
Leads
Price
$121
Day move
+2.62%
AIQ Score
57/100
Best edge
Value
Sector
Healthcare

What is the main difference between IDYA and INSM?

INSM leads the current stock comparison as Insmed Incorporated, with the clearest separation coming from value and the broader AIQ evidence mix.

AlgovestIQ AIQ Comparison

IDEAYA Biosciences, Inc. vs Insmed Incorporated

Data as of Nov 15, 2026· market close· Healthcare· Coverage 64/66 fields· High confidence
AIQ VerdictFragileAIQ Comparison Conviction 3/10

INSM leads

INSM leads by 3 AIQ points, primarily on Value and Quality, having only recently taken the lead back from IDYA.

Fragile: 3 of 6 evidence groups support INSM, the lead recently changed hands, and its current signal state is conflicted.

Evidence agreement: 3 of 6Comparison trend: Reversed
IDYA

IDEAYA Biosciences, Inc.

AIQ Score
54/100
AIQ Edge Score
5/10
INSM

Insmed Incorporated

Leads
AIQ Score
57/100
AIQ Edge Score
6/10

The Algovestiq AIQ Score currently favors INSM over IDYA, 57 versus 54 as of Nov 15, 2026. INSM's advantage is driven primarily by stronger value and quality, while IDYA holds the stronger risk resilience profile. INSM also shows the stronger technical structure relative to its 50-day moving average. 3 of 6 covered evidence groups favor INSM today, and the comparison is rated Fragile on stability: the AIQ gap is narrow at 3 points. INSM lead: Reversed — IDYA led by 17 AIQ points 30 sessions ago; INSM now leads by 3.

Compare IDEAYA Biosciences, Inc. and Insmed Incorporated across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.

Currently unavailable

Performance over time

Price return from daily closes; distributions are not included.

IDYA
+34.4%
INSM
+299.2%

Price return comparison

Growth of $10,000, price only

IDYA $13,442 · INSM $39,921

Split-adjusted closes only. Distributions are excluded, which understates the return of any fund or stock that pays them.

Compare IDYA and INSM against another ticker

Open a multi-ticker workspace without changing this focused pair page.

Basic: 2 symbols·Explorer: 3 symbols·Pro and Premium: 5 symbols·Your limit: 2

AIQ Factor Divergence

Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.

IDYA advantage
0
INSM advantage
  • Value39 vs 55
    INSM +16
  • Risk Resilience61 vs 49
    IDYA +12
  • Quality51 vs 58
    INSM +7
  • Momentum63 vs 61
    Even

3 of 6 evidence groups favor INSM. INSM’s edge is concentrated in value and quality; IDYA keeps a meaningful risk resilience edge.

What changed since the last close

Latest scored session 2026-11-13, compared against the prior scored session 2026-11-12.

IDYA0 AIQ

Largest factor move: Value +2, not enough on its own to move the overall score.

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
INSM+1 AIQ

Largest factor move: Momentum +3

New signals

  • ADX Trend Strengthening — neutral, trend, medium horizon

INSM's lead widened by 1 AIQ point in the latest session.

Deeper signal detail for each name lives on its own signals page — IDYA and INSM both carry a full feed there.

The central trade-off

INSM (Insmed Incorporated): the stronger current systematic profile, led by value and quality.

IDYA (IDEAYA Biosciences, Inc.): the counter-case, on risk resilience, fundamentals.

Which one fits your objective

The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.

Balanced

INSM

INSM on the overall AIQ Score, which weights Quality and Value most heavily.

Growth

Even

Growth figures are not covered for both names.

Value

INSM

INSM on the peer-relative Value factor, by 16 points.

Momentum

Even

The two are level on Momentum.

Lower downside

IDYA

IDYA on Risk Resilience, by 12 points.

Analyst upside

INSM

INSM on implied upside to the consensus price target.

AIQ vs Wall Street

Where the systematic read and the analyst consensus line up — and where they do not.

MeasureIDYAINSMNote
Implied upside to target+53.2%+57.7%INSM has more room
Target dispersion+36.9%+30.9%Lower is tighter analyst agreement
ConsensusBuyBuyContext, not a primary driver
Analysts covering1624Higher coverage generally improves confidence

Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.

AIQ Agreement Matrix

3 of 6 covered evidence groups favor INSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.

Evidence groupFavorsReading
AIQ ScoreEven54 vs 57
FundamentalsIDYAon balancerevenue growth 15.6% vs 23.3%; TTM ROE -11.5% vs -13.8%; gross margin 100% vs 84.3%; operating margin -12.7% vs -35.6% — IDYA takes 3 of 4 decided legs, not all of them
ValuationINSMValue 39 vs 55
TechnicalsINSMPrice vs 50-day -10.3% vs 9.3%; vs 200-day -6% vs -1.6%
Risk ResilienceIDYARisk Resilience 61 vs 49
Analyst expectationsINSMTarget upside 53.2% vs 57.7%

✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of IDYA and INSM and are excluded from the count.

AIQ Decision Stability

Fragile

The conclusion is sensitive to small changes. Treat the lead as provisional and watch the flip conditions below.

  • The AIQ gap is narrow at 3 points. (argues the conclusion is provisional)
  • Only 3 of 6 covered evidence groups agree. (argues the conclusion is provisional)
  • The lead has already changed hands inside the comparison window. (argues the conclusion is provisional)
  • The lead has swung materially session to session. (argues the conclusion is provisional)
  • The leader is throwing conflicting signals. (argues the conclusion is provisional)

Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on INSM.

How the comparison changed

120 daily snapshots · May 27 – Nov 13

INSM lead: Reversed — IDYA led by 17 AIQ points 30 sessions ago; INSM now leads by 3.

May 27IDYA leads above the line · INSM leads belowNov 13
Today
INSM +3
54 vs 57
7 sessions ago
INSM +2
54 vs 56
30 sessions ago
IDYA +17
63 vs 46
90 sessions ago
IDYA +14
65 vs 51

The lead changed hands once in this window, most recently on Nov 6 when INSM moved ahead of IDYA.

AIQ Signal Divergence

Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.

IDYA

4 bullish / 0 bearish / 2 neutral

Only IDYA

  • Golden Cross Active — bullish, trend, long horizon (4.78%)
  • MACD Histogram Expanding Bullish — bullish, momentum, short horizon
  • OBV Bullish Divergence — bullish, volume, medium horizon (-3.1%)
  • RSI Bullish Divergence — bullish, momentum, medium horizon
INSMConflicted

2 bullish / 2 bearish / 2 neutral, conflicted

Only INSM

  • Death Cross Active — bearish, trend, long horizon (11.14%)
  • Keltner Channel Breakout — bullish, volatility, short horizon
  • Low Volume Rally Warning — bearish, volume, short horizon (0.41x)
  • TRIX Bullish Signal — bullish, momentum, short horizon

Both carry 2 more signals that do not separate them: ADX Trend Strengthening, ATR Expansion - Breakout Mode.

INSM leads the comparison while carrying a conflicted signal state, which is one reason the stability rating is not higher.

Price vs model alignment

Whether the latest session's price move confirms what the model did over the same session, or contradicts it.

IDYANo material change

Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price +1.08%, AIQ 0 points).

INSMConfirmed strength

Price and the AIQ Score both moved up over the latest session (price +2.62%, AIQ +1 points).

What would flip this result

A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.

  1. 1IDYA closes the Value gap — currently 16 points behind, the largest single contributor to INSM's edge.
  2. 2IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish.
  3. 3INSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once.
  4. 4A market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

The full evidence

Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.

Fundamentals

IDYA leads on balance
MetricIDYAINSM
Revenue growth (YoY)15.6%23.3%
EPS growth (YoY)0%-6.7%
Gross margin100%84.3%
Operating margin-12.7%-35.6%
Return on equity (TTM)-11.5%-13.8%
Debt to equity0.031.02

Performance

Split across windows
MetricIDYAINSM
1 week (5 sessions)1.9%5.9%
1 month (20 sessions)-3.1%25.9%
3 months (63 sessions)-12.9%-5.6%
6 months (126 sessions)12.8%11%
Year to date-7.9%-30.4%
1 year (252 sessions)-0.4%-37.7%

Technicals

INSM has the stronger structure
MetricIDYAINSM
RSI (14)42.465
ADX (14)25.830.8
Price vs 50-day-10.3%9.3%
Price vs 200-day-6%-1.6%
Volatility (1M, annualized)48.2%65.3%

Risk

IDYA is the more resilient
MetricIDYAINSM
Beta0.940.55
Sharpe ratio0.14-0.48
Sortino ratio0.2-0.72
Max drawdown-27.8%-56.5%
Current drawdown-25.1%-42.7%
Annualized volatility44.9%63.1%
Value at risk (95%)-4.1%-4.5%

Straight answers

Each answer is regenerated from the current snapshot, not written once and left to age.

Which is better, IDYA or INSM?

On the Algovestiq AIQ Score, INSM is the stronger of the two as of Nov 15, 2026, scoring 57 against IDYA's 54. The edge comes from value and quality. IDYA is not without a case — it holds the better risk resilience profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.

Is IDYA or INSM the better buy right now?

INSM carries the stronger systematic profile as of Nov 15, 2026, and the comparison is rated Fragile — 3 of 6 covered evidence groups agree. A Fragile rating means the conclusion is sensitive: the AIQ gap is narrow at 3 points. Treat the lead as provisional.

Why does the AIQ Score favor INSM over IDYA?

The composite weights Quality, Value, Momentum and Risk Resilience. INSM leads Value by 16 points; IDYA leads Risk Resilience by 12 points; INSM leads Quality by 7 points. Where the two split, the factor with the larger weight carries the result.

Which has more analyst upside, IDYA or INSM?

Analyst price targets imply +53.2% upside for IDYA and +57.7% for INSM, so the Street currently favors INSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.

Which is better value, IDYA or INSM?

INSM is the better-valued of the two on the peer-relative Value factor. INSM on the peer-relative Value factor, by 16 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.

Which has stronger growth, IDYA or INSM?

Growth figures are not covered for both names. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.

Which has stronger momentum, IDYA or INSM?

The two are level on Momentum. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.

Which is riskier, IDYA or INSM?

IDYA is the more resilient of the two, so the other name carries the higher downside risk. IDYA on Risk Resilience, by 12 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.

Is IDYA more profitable than INSM?

IDYA leads on the comparable margin measures — gross margin 100% vs 84.3%; operating margin -12.7% vs -35.6%; ttm roe -11.5% vs -13.8%.

Is INSM's lead over IDYA getting stronger or weaker?

INSM lead: Reversed — IDYA led by 17 AIQ points 30 sessions ago; INSM now leads by 3. This is measured from 120 daily comparison snapshots between 2026-05-27 and 2026-11-13. The lead has changed hands once in that window, most recently on 2026-11-06, when INSM moved ahead of IDYA.

What would change the IDYA vs INSM verdict?

The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: IDYA closes the Value gap — currently 16 points behind, the largest single contributor to INSM's edge; IDYA generates a confirmed bullish trend signal it does not currently carry, such as MACD Bullish Crossover or EMA Ribbon Expansion Bullish; INSM's conflicting signal state resolves bearish — it currently carries 2 bullish and 2 bearish rules at once; a market regime shift would change the factor readings behind both scores; a rotation toward or away from quality, value or momentum could move the result.

What do the current signals say about IDYA and INSM?

IDYA: 4 bullish / 0 bearish / 2 neutral. INSM: 2 bullish / 2 bearish / 2 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on IDYA is Golden Cross Active (bullish, long horizon). On INSM it is Death Cross Active (bearish, long horizon).

Compare IDYA and INSM with others

Continue your research

This page answers which of the two. These answer the questions on either side of it.

How this comparison is scored

The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.

The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.

How to use side-by-side comparison →

This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.